Firma Clinical Research
We are a quality-certified, global CRO.
We are a quality-certified, global CRO.
Firma Clinical Research, a quality-certified, global CRO, was founded in 2017 in the United States. The company specializes in supporting the drug development efforts of pharmaceutical and biotech companies through a range of services including advanced in-home patient visits, data management & biostatistics, medical writing, regulatory consulting, clinical pharmacology, and clinical operations. With a focus on accelerating the development of safe and effective treatments for the pharmaceutical, biotechnology, and medical device industries, Firma Clinical stands out for its collaborative approach. Their last Private Equity Round investment was made on 16 July 2018, with the participation of Northlane Capital Partners. For further details, visit www.firmaclinical.com.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Private Equity Round | Unknown | 1 |
|
16 Jul 2018 |
No recent news or press coverage available for Firma Clinical Research.
We care about your data, and we'd love to use cookies make your experience better.
